Epidemiology
Risk factors
Symptoms
Prevention
Screening
Diagnosis
Staging
Prognosis
Surgery
Immunotherapy
Radiotherapy
Chemotherapy
Cytotoxic drugs
Vaccines
Combination therapy
Alternative treatments
Stage-specific treatment
Recurrent melanoma treatment
Neoadjuvant
Adjuvant treatment
Interferon-alpha treatment
interleukin-2
Dacarbazine
Cisplatin
Carboplatin
Carmustine
Lomustine
Melphalan
Paclitaxel
Tamoxifen
Temozolomide
Vinblastine
Vincristine
Combination regimens
Chemotherapy regimens
Biochemotherapy
Electrochemotherapy
Treatment variations
Significant developments
Early diagnosis
Public awareness
Genetic profiling
Clinical trials
Vaccines
Melacine
M-Vax
Canvaxin
Oncophage HSPPC-96
GMK
Genasense oblimersen
Virulizin
Ceplene histamine
Thalomide Revimid
Taxoprexin
Allovectin
pegylated interferon
Avastin bevacizumab
BAY 43-9006
Tracleer bosentan